Clinical Trial Update: Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating aspirin (acetylsalicylic acid) for colorectal cancer prevention by examining its platelet-related mechanism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Aragon Institute of Health Sciences | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN